Question

consider this claim: prescription drugs should not be advertised directly to consumers because of the potential risk of misinforming the public. which is the strongest evidence to support the claim? researchers at dartmouth college analyzed pharmaceutical spending trends over a twenty - year span and found that spending on consumer direct - to - consumer advertisements increased from $2.1 billion in 1997 to $9.6 billion in 2016. according to a study published in a medical journal, fifty - five percent of the claims made in drug ads to consumers were considered \potentially misleading\ and two percent were \false.\ a survey investigating the consumer impact of advertisements for prescription drugs found that one - third of respondents have asked their doctors for more information about a drug they learned about from an ad.

Explanation:

The claim is about misinforming the public through prescription - drug direct - to - consumer advertising. The second option provides evidence of the actual misinformation in drug ads, stating that 55% of claims were potentially misleading and 2% were false, which directly supports the claim. The first option only shows the increase in advertising spending, and the third option shows consumers asking for more info but not misinformation.

Answer:

According to a study published in a medical journal, fifty - five percent of the claims made in drug ads to consumers were considered "potentially misleading" and two percent were "false."